Innovation versus Financialization in the US Pharmaceutical Industry (Bog, Hardback, Engelsk)
  1. Forside
  2. Bøger
  3. Engelske bøger
  4. Sundhedsøkonomi
  5. Kemisk, bioteknologisk og farmaceutisk...
  6. Sundhedslovgivning
  7. Sygesikring
  8. Innovation versus Financialization in the US Pharmaceutical...

Innovation versus Financialization in the US Pharmaceutical Industry

(Bog, Hardback, Engelsk)
Forfattere: Oner (The Academic-Industry Research Network) Tulum, William (The Academic-Industry Research Network) Lazonick
Forlag: Cambridge University Press

Bemærk: Kan ikke leveres før jul.

Når du handler på WilliamDam.dk, betaler du den pris du ser.

  • Ingen gebyrer
  • Ingen abonnementer
  • Ingen bindingsperioder

Relaterede kategorier

Kemisk, bioteknologisk og farmaceutisk industri Sundhedslovgivning Sundhedsøkonomi Sygesikring
  = Emner / kategorier
  = Sektioner / guides
  = Specialsider
  = Kampagner

Beskrivelse

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'

Læsernes anmeldelser (0)

Alle detaljer

Forlag Cambridge University Press
Forfattere Oner (The Academic-Industry Research Network) Tulum, William (The Academic-Industry Research Network) Lazonick
Type Bog
Format Hardback
Sprog Engelsk
Udgivelsesdato 20-11-2025
Første udgivelsesår 2025
Serie Elements in Corporate Governance
Illustrationer Worked examples or Exercises
Originalsprog United Kingdom
Sideantal 96
Indbinding Hardback
Forlag Cambridge University Press
Sideoplysninger 96 pages, Worked examples or Exercises
ISBN-13 / EAN-13 9781009707992